{"name":"Terns Pharmaceuticals","slug":"terns","ticker":"TERN","exchange":"NASDAQ","domain":"ternspharma.com","description":"Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for metabolic and other diseases. The company's pipeline includes several promising candidates, including TERN-1411, a potential treatment for non-alcoholic steatohepatitis (NASH). With a strong therapeutic focus on metabolic diseases, Terns aims to address significant unmet medical needs and improve patient outcomes. As a relatively new player in the industry, Terns has significant growth potential.","hq":"Foster City, CA","founded":0,"employees":"","ceo":"Mark Vignola","sector":"Metabolic / MASH","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$600M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":-96207000,"cash":524747000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"TERN-1411 patent cliff ($0.00 at risk)","drug":"TERN-1411","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Terns Pharmaceuticals reported its fourth quarter and full year 2023 financial results, highlighting progress in its clinical pipeline and strong cash position.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Terns Pharmaceuticals Announces Collaboration with Leading Research Institution","summary":"Terns Pharmaceuticals announced a collaboration with a leading research institution to advance its pipeline of innovative treatments for metabolic diseases.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQzRxcmxFM29rZXoweHRVQVVLaVdvVktiX0NadC1HSmQtdmJQTUJhNzI0UlN4SVg4SEFpWjJkUTJSc2otUkJBNkgxb09WdHAzRGVfVDZUdFBZd2RIbVFDMXlmcC1ESWp2LTJ4ZU9ZR19NSlFSaVFKWU9FX1ViZDczdl9sNGswaWRRd0p0YTB4eDFQZ0hvUTM5bFNJU2FUNDNNQVpnQ0ljYVdUNlln?oc=5","date":"2026-04-07","type":"trial","source":"Endpoints News","summary":"Merck got a peek at Terns' leukemia data during its deal talks — and decided to lower its bid by $1B - Endpoints News","headline":"Merck got a peek at Terns' leukemia data during its deal talks — and decided to lower its bid by $1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQalBtcDcwQUpKWWp5MkFSeFd1S0otWkZfS0I3V0EzTzVmamFud1lPTzFVaURkcE5tVmRLSURqQmhPbkhGd3FucGtmTldzQTRkRVBHdDBkVXdEeTBoejh3UEdyVVlzWFhiODYtSGZDdkU4T1QxSkZsMXZRNE0xdnNaSlUzZlp2bXE1c1BsaGNkeUpvRk9tU1VMc2RsdGhxZzBnWkFPaFV0dkdqU3VwRE82Qk8yTVZhamNfZm5n?oc=5","date":"2026-04-02","type":"pipeline","source":"Stock Titan","summary":"Three new Terns employees get 23,316 stock units over 4 years - Stock Titan","headline":"Three new Terns employees get 23,316 stock units over 4 years","sentiment":"neutral"},{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQQWZpb2hJZ3VQM0doY08taFRFNTM3TDN2OXRrSWFiTVlFUU03OHNKbEloOUhIcTh0SXp5LWtwS09sQnRCbE5vSE85WElJTUlIeWZrU3ZoWjRsbWQ5RUNTMzRzcUMyWldjdnVJVkU1Z093Z05PdUtFZkU1YUlwdlVxX1BTS0pOWUwxTUlRMUd4WEhDZ2ZUY1Z1VnhpMGIzQ2dud1HSAacBQVVfeXFMTTA3VndQZWRkSHB4elRHVldoUDFiLW9FdWxPejBHZExOaFZ5ZWZXeDhpX1pqSmR0dlhiSFQ4N19vOVVmVXl6eURLelNfVkJEaERHUlRicnQ4LWF6Nm43ZUlOU0N6Y3VqV0EzaGlOS21MdEE5UTd1aWVucUxkRnpxZndWZHNWVGFiQUM2c29XMkk0WlV3OENQcHZSN3FpV2I4bGlZNlBKckU?oc=5","date":"2026-03-25","type":"deal","source":"cnbc.com","summary":"Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - cnbc.com","headline":"Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNdHVKaVdobWdBVVhvNEJ1TEF6TlRvVWk4SUVxaHJrdDcxSXQtVUVnNklPdlhEYTVfbjA4WE9jVmpFeHdZM1R3ektSM0IzTjJLdFdkNmVoWE5ZMzg3anVsMEdiWXBnQ3JoQjl2aUNFSVhsRUxaM0NVUXNhdkZvcXo3M2VpQnJzRWJZM3ppVENrZDNoM0xWYjd1M3NqOWZnSjJhTnVwM2RTZFFsWUN0ampzMnluYUFNdEVLSEN2bFRxLUpNdmw4cElWMXhIbVRmOEduejhTQ1dvR2NJVUlFRmUyVElucFhHanN2dTFZaWVkOXpsRE1ueTRON1poX3pYV0R5MHZJSV9JSGMwd1ZxOTloWXlsM05OZUk0TjJNa21Xa3hmU2JheVE?oc=5","date":"2026-03-25","type":"regulatory","source":"Business Wire","summary":"Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - Business Wire","headline":"Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNNU85RUgxUXZPN0F2UG5jYktaSkEycVVJdURwckJ0N244eVV5anFScGcwTU5uUENBcTdUMHE5VHBJa2YtLUxoRG5fTWZzR0toSEplNEZFSTJJQTNqeWdOSEY1OTBRZVNIbjlfY3RMaHNGYUhDNGJwczA0bTIyN01TTURDd0xHdTMw?oc=5","date":"2026-03-25","type":"deal","source":"BioPharma Dive","summary":"Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug - BioPharma Dive","headline":"Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQRHNPQVNLbVlNTWdRcF9KZWx5eW5MLVdra3Q4NGZFY2xGUWN1T3h5UFFOMXd5WTFsY2FOVVFYbnNXdzlDWUFfSHRYcVh0Y0Z2MnUwUzJxd19zaXl5ejlERzQ4ektPeEN0dFRlTjBtNDRTb0lVLWZLYzZJRk9PaHNPTHVGeXNPRkdfR0pjam02NGhQUkNqclBDRW0tY2RVN183dlpzcWVtTVBxZkUxMV9lalVOaVNoQ2JxcmlWdXRSVmE0aEI0djNwdlMzM2hWZVRV?oc=5","date":"2026-03-25","type":"pipeline","source":"Reuters","summary":"Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters","headline":"Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNc1R3Qmp2UU16dm93YVVKc1o4LUhtVFQ4U19MQk9fbmlXdDBPcEo0WGwwa2Y1X3Y0SEt4ejFmcXQwcTJXM1ZNRzdHdmp0VE9wbHBxeG9mVXk5bGU0RDZKWEc5VG5FUXFSUjcyS3Nrdjc0Z055dURyOWIzcEU4SFJLRmpmTVpId3Uwc2xpMEZscHNNZ1dwNWc0a0pGemZaT0U?oc=5","date":"2026-03-25","type":"pipeline","source":"Fierce Biotech","summary":"Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition - Fierce Biotech","headline":"Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZjdTeEdNU1JSSlk4Tlk0MUREVVpDbHFLTENBeFhTaTJtTTZZd2xaZlVlNThBYVdrQjlrMm9ZN0JiUjlXRHpsVGZINmhIMExja1c2czVKSU9ZUllxMXNRZGxGWmw1MFJTQXI5bW9pb0htOWpISTBGRWRLLWpfd2xndzZQTnN0V2dh?oc=5","date":"2026-03-25","type":"deal","source":"statnews.com","summary":"Merck to buy Terns Pharmaceuticals in $6.7B deal - statnews.com","headline":"Merck to buy Terns Pharmaceuticals in $6.7B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQdnZPXy1VSl9tRUs5bUlCYnJxekhkYWZ6WTd1NHl0WEZqbE5JaXNjVmdzalJjY1NkbTBFaHM5VUJhQXVtQ1FuZWlXMTQ5LVdOOG85V0ZBNWZXUjRyUkJpZGx4QklRcE51WHBTT3J2OGhFU3Y5MGRfaVBMUm5QeGlsdUtEbG5JaTA2b05raFFNRnZqQQ?oc=5","date":"2026-03-25","type":"deal","source":"New Jersey Business & Industry Association","summary":"Merck to Acquire Terns Pharma, Boosting Oncology Pipeline - New Jersey Business & Industry Association","headline":"Merck to Acquire Terns Pharma, Boosting Oncology Pipeline - New Jersey Business & Industry Association","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQdFAxcmQ0R0dFYXV4MlIySFBhTWRpcjZwMmFUOWoxU0E3QXM3NnliNTRwVHNMVWN2YzN6amdoU1BNTUpGMEl0c3RTMUV1NUZMVXA3d3hYWTg1bzM5ZjZudlNCOG5kQjdBUlRXODV5TFVsZWhGLWc4QTYwNUVHQTBTTk9PSGFqMEMteTFmVVE3QkFZM1o0S2lmcmxwOTZFX2dUSFUxUndR?oc=5","date":"2026-03-25","type":"deal","source":"WSJ","summary":"Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns - WSJ","headline":"Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQSjlabGZGTjI3ZVdjRnhydjNNTllKTzdoaDZOS29CcGR0djQ4OFBJU0dHdU91UmF4TGpBczlqbHBXb2wyUlQtZE9GWEd3b0xQWEhoZW5pblRrQ3pUTHFvdjRJUUVzYlRtZTQ0ZlBVN2pyUkRYRHVkR3R2MUFfRG50X0JoQ25VSk5DYlk1N1o3bTZvdzZkYmRRWXpsUEpKNnVQYkU0bmo0NTMxbUlFN0E?oc=5","date":"2026-03-25","type":"deal","source":"bloomberg.com","summary":"Merck to Buy Terns for $6.7 Billion to Grow in Blood Cancers - bloomberg.com","headline":"Merck to Buy Terns for $6.7 Billion to Grow in Blood Cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQWDdIRHpEaHE5MENRSWxBc2w0Uk1IbGprRmNIUTlCdnYtbFNXQnBHUE0yanBPZm5oNGc3YTFjckpRYjFzZmg3VHFMdm43VFVycVg4VTBkbnRrSzJOLXJHU1dCeEF3Nk1VRkxJSVNkVDRtcTN0dTY3TmRxd1BXejMyTVVrZkgxVmRldWlGRGdRUDR1U2dTekxR?oc=5","date":"2026-03-25","type":"pipeline","source":"The Pharma Letter","summary":"Merck bids $6.7 billion for Terns Pharmaceuticals - The Pharma Letter","headline":"Merck bids $6.7 billion for Terns Pharmaceuticals","sentiment":"neutral"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[{"drugName":"TERN-1411","drugSlug":"generic-name-not-publicly-disclosed","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Gilead Sciences","Regeneron Pharmaceuticals","Novo Nordisk"],"therapeuticFocus":["Metabolic Diseases","NASH"],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":0,"period":"2022-12-31"},{"value":1000000,"period":"2021-12-31"},{"value":0,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-96207000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":524747000,"cashHistory":[],"totalAssets":1025078000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}